Skip to main navigation
Editas Medicine
  • The DNA of Editas
    • Company Overview
    • Our Culture
    • Our Team
  • What is CRISPR?
  • Genome Editing
  • Our Programs
    • Areas of Research
    • Our Pipeline
    • Presentations & Publications
  • Be a Part of the Team
    • Community
    • Careers at Editas
  • Investors & Media
  • Contact

  • 11/12/19
    Summary ToggleEditas Medicine Announces Third Quarter 2019 Results and Update
read more more news

Media & Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor FAQs
  • Information Request
  • Contact

SEC Filings

Form
8-K
Filing Date
Nov 12, 2019
Document Date
Nov 12, 2019
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Editas Medicine
Issuer
Editas Medicine, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - EX-101.SCH
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
           
Editas Medicine Logo Footer
  • The DNA of Editas
  • What is CRISPR?
  • Genome Editing
  • Our Programs
  • Be a Part of the Team
  • Investors & Media
  • Contact
  • Copyright © 2017 Editas Medicine
  • Terms of Use
  • Privacy Policy
Editas Medicine Logo Footer
  • Terms of Use
  • Privacy Policy
  • Contact
  • Copyright © 2017 Editas Medicine